Systematic Review of Discriminating Power of Outcome Measures Used in Clinical Trials of FibromyalgiaCARVILLE, Serena F; CHOY, Ernest H. S.Journal of rheumatology. 2008, Vol 35, Num 11, pp 2094-2105, issn 0315-162X, 12 p.Article

Cytokine pathways and joint inflammation in rheumatoid arthritisCHOY, Ernest H. S; PANAYI, Gabriel S.The New England journal of medicine. 2001, Vol 344, Num 12, pp 907-916, issn 0028-4793Article

What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient Global Impression of Improvement and Changes in Clinical Symptoms and Function: A Pooled Analysis of 4 Randomized Placebo-controlled Trials of DuloxetineHUDSON, James I; ARNOLD, Lesley M; BRADLEY, Laurence A et al.Journal of rheumatology. 2009, Vol 36, Num 11, pp 2517-2522, issn 0315-162X, 6 p.Article

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumaticaHUTCHINGS, Andrew; HOLLYWOOD, Jane; GENDI, Nagui et al.Arthritis care and research. 2007, Vol 57, Num 5, pp 803-809, issn 0893-7524, 7 p.Article

Adalimumab for long-term treatment of psoriatic arthritis : Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trialGLADMAN, Dafna D; MEASE, Philip J; RITCHLIN, Christopher T et al.Arthritis and rheumatism. 2007, Vol 56, Num 2, pp 476-488, issn 0004-3591, 13 p.Article

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis : Results of a double-blind, randomized, placebo-controlled trialMEASE, Philip J; GLADMAN, Dafna D; RITCHLIN, Christopher T et al.Arthritis and rheumatism. 2005, Vol 52, Num 10, pp 3279-3289, issn 0004-3591, 11 p.Article